HB3539, the “Leadership in Critical and Emerging Technologies Act,” would direct the Director of the U.S. Patent and Trademark Office to create a pilot program to speed up examination of certain patent applications. The program would apply to “covered applications” that claim inventions in specified critical or emerging technologies, including artificial intelligence, semiconductor design and electronic design automation tools, and quantum information science. The bill defines those technology categories broadly, covering areas such as machine learning, foundation models, generative AI, synthetic data, quantum computing, quantum sensing, and quantum communications.
The pilot program would have to be established within one year of enactment and would use the existing patent “petition to make special” process to move qualifying applications ahead of the normal queue. The Director would be authorized to set additional participation rules by regulation, waive certain fees or accelerated-examination requirements, and consult with other federal agencies as needed. To qualify, applicants could not be foreign entities of concern, and the application would have to be a noncontinuing, nonprovisional original utility patent application without domestic benefit claims. The program would end after five years or after 15,000 accepted applications, whichever comes first, with a possible renewal and a required report to Congress on its effectiveness.
The bill’s impact would be on federal patent administration rather than state law. It would affect the USPTO, patent applicants, and industries working in AI, semiconductors, and quantum technologies by potentially shortening time to examination and patent issuance for selected inventions. It also creates public reporting requirements and a post-termination assessment, which could influence future patent policy if the pilot is extended or made permanent.
The general sentiment reflected in the bill text is supportive of accelerating innovation and maintaining U.S. leadership in strategically important technologies. Because there are no committee transcripts or recorded votes provided, there is no evidence of formal opposition or amendment debate in the available materials. The bill’s structure suggests a policy preference for prioritizing domestic innovation capacity while screening out applicants tied to foreign entities of concern.
The main points of contention likely center on which technologies and applicants should receive expedited treatment, whether the USPTO should devote special processing resources to these applications, and whether the foreign-entity restriction and inventor-application limits are too narrow or too broad. Another possible issue is whether faster examination for some fields could create fairness concerns for other patent applicants who remain in the standard queue.
HB3539 would not change state statutes; it would amend federal patent administration by requiring the USPTO to run a temporary pilot program for expedited examination of qualifying patent applications. The bill would affect patent applicants in AI, semiconductors, and quantum technologies, and it would authorize the USPTO to set participation rules, waive certain fees or requirements, and report program data and outcomes to Congress.
The available materials show a generally positive, pro-innovation sentiment. The bill is framed as a way to strengthen U.S. leadership in critical and emerging technologies by speeding patent review for selected applications. No committee transcript or vote record is provided, so there is no documented floor or committee opposition in the supplied context.
No formal debate is included in the provided materials, but the likely areas of contention are the scope of the eligible technologies, the exclusion of foreign entities of concern, and the limit on how many covered applications an inventor may have in the program. Stakeholders could also disagree over whether expediting these applications is an efficient use of USPTO resources or whether it creates unequal treatment among patent applicants.